Clinical Trials in San Jose, Alajuela

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

NCT ID: NCT04961996

This clinical trial, called the lidERA Breast Cancer study, is looking at a new treatment called giredestrant for patients with early breast cancer that is positive for estrogen receptors and negat...